Faruqi & Faruqi, LLP Announces Investigation of Novellus Systems, Inc. (NVLS) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Novellus Systems, Inc. (“Novellus” or the “Company”) (NASDAQ: NVLS) for potential breaches of fiduciary duties in connection with... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Morton’s Restaurants Group Inc. (MRT) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Morton’s Restaurants Group Inc. (“Morton’s” or the “Company”) (NYSE: MRT) for potential breaches of fiduciary duties in... READ MORE

In this case, nicknamed Lipitor, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Pfizer’s branded blockbuster cholesterol drug Lipitor (atorvastatin calcium), and direct purchasers of generic Lipitor manufactured by Ranbaxy.  The case alleges that Pfizer and its predecessors and affiliates engaged in... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Synovis Life Technologies, Inc. (SYNO) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) (NASDAQ: SYNO) for potential breaches of fiduciary duties in... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of SonoSite, Inc. (SONO) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of SonoSite, Inc. (“SonoSite” or the “Company”) (NASDAQ: SONO) for potential breaches of fiduciary duties in connection with their conduct... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Focus Media Holding Limited Faruqi & Faruqi, LLP, a leading national securities firm, is investigating potential securities fraud at Focus Media Holding Limited (“Focus Media” or the “Company”) (Nasdaq: FMCN). The investigation focuses on whether the Company and its executives violated federal securities... READ MORE

Faruqi & Faruqi, LLP Files Class Action Lawsuit Against GLG Life Tech Corporation (GLGL) New York, December 15, 2011 – Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York on behalf... READ MORE

In the Effexor XR case, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Wyeth’s (now Pfizer’s) branded antidepressant drug Effexor XR (extended-release venlafaxine hydrochloride capsules).  The class also includes direct purchasers of generic versions of Effexor XR from Teva, Wyeth’s co-defendant and... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Career Education Corp. Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Career Education Corporation (“Career Education” or the “Company”) (Nasdaq: CECO). On August 3, 2011, Career Education disclosed that the Company identified “improper practices …... READ MORE

Faruqi & Faruqi represents a proposed class of pediatricians and pediatric practice groups challenging Sanofi-Pasteur, Inc.’s illegal maintenance of a monopoly on the children’s vaccine Menactra in violation of  § 2 of the Sherman Act.  Plaintiffs allege a scheme where Sanofi-Pasteur employs a series of anticompetitive and exclusionary bundling and... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of DemandTec, Inc. (DMAN) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of DemandTec, Inc. (“DemandTec” or the “Company”) (NASDAQ: DMAN) for potential breaches of fiduciary duties in connection with their conduct... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Talbots Inc. (TLB) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Talbots Inc. (“Talbots” or the “Company”) (NYSE: TLB) for potential breaches of fiduciary duties in connection with their conduct... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of SuccessFactors, Inc. (SFSF) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of SuccessFactors, Inc. (“SuccessFactors” or the “Company”) (NYSE: SFSF) for potential breaches of fiduciary duties in connection with their conduct... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of IntraLinks Holdings, Inc. (IL) Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at IntraLinks Holdings, Inc. (“IntraLinks” or the “Company”) (NYSE: IL).  The investigation focuses on whether the Company and its executives violated federal securities laws... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Pain Therapeutics, Inc. (PTIE) Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Pain Therapeutics, Inc. (“Pain Therapeutics” or the “Company”) (Nasdaq: PTIE).  The investigation focuses on whether the Company and its executives violated federal securities... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Primo Water Corporation (PRMW) Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Primo Water Corporation (“Primo Water” or the “Company”) (NASDAQ: PRMW).   The investigation focuses on whether the Company and its executives violated federal securities... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of David Lerner Associates, Inc. Faruqi & Faruqi, LLP, a leading national securities firm, is investigating potential securities violations by David Lerner Associates in the sale of DLA’s “Apple REIT” products. The investigation focuses on whether DLA violated the law by: (1) misleading investors,... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Pacific Biosciences of California, Inc. (PACB) Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Pacific Biosciences of California, Inc. (“PacBio” or the “Company”) (Nasdaq: PACB).  The investigation focuses on whether the Company and its executives... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Magma Design Automation Inc. (LAVA) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Magma Design Automation Inc. (“Magma Design” or the “Company”) (NASDAQ: LAVA) for potential breaches of fiduciary duties... READ MORE

Faruqi & Faruqi, LLP Announces Investigation of Commercial Metals Company (CMC) Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Commercial Metals Company (“Commercial Metals” or the “Company”) (NYSE: CMC) for potential breaches of fiduciary duties in connection... READ MORE